FIELD: medicine; pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmaceutics and discloses the use of methyl 5-benzoyl-4-hydroxy-6-(4-chlorophenyl)-2-thioxohexahydropyrimidine-4-carboxylate (1) as an agent possessing analgesic and anti-inflammatory action.
EFFECT: invention provides effective analgesic and anti-inflammatory action.
1 cl, 3 tbl, 2 ex
(1)
| Title | Year | Author | Number |
|---|---|---|---|
| ETHYL 4-(5-BENZOYL-6-(4-(DIETHYLAMINO)PHENYL)-4-HYDROXY-2-THIOXOHEXAHYDROPYRIMIDIN-4-CARBOXAMINO)BENZOATE, EXHIBITING ANALGESIC AND ANTI-INFLAMMATORY ACTION | 2019 |
|
RU2717246C1 |
| USE OF 5-BENZOYL-4-HYDROXY-N-(4-IODOPHENYL)-6-(4-CHLOROPHENYL)-2-OXOHEXAHYDROPYRIMIDINE-4-CARBOXAMIDE AS AGENT WITH ANALGESIC ACTIVITY | 2023 |
|
RU2811249C1 |
| APPLICATION OF METHYL 5-BENZOYL-6-(4-FLUOROPHENYL)-4-METHOXY-2-THIOXOHEXAHYDROPYRIMIDINE-4-CARBOXYLATE AS AN ANTI-INFLAMMATORY AGENT | 2022 |
|
RU2786805C1 |
| ANALGESIC AGENTS BASED ON 5-ARYL-4-BENZOYL-3-HYDROXY-1-(4-GUANIDYLSULFONYLPHENYL)-3-PYRROLIN-2-ONES | 2016 |
|
RU2644161C2 |
| USE OF METHYL 5-(4-BROMOBENZOYL)-4-METHOXY-6-(4-FLUOROPHENYL)-2-OXOHEXAHYDROPYRIMIDINE-4-CARBOXYLATE AS AGENT WITH ANTI-INFLAMMATORY ACTIVITY | 2023 |
|
RU2811248C1 |
| USE OF 4-(4-BROMOPHENYL)-6-METHYL-N-(2-CHLOROPHENYL)-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOXAMIDE AS AN AGENT WITH ANALGESIC ACTIVITY | 2022 |
|
RU2793550C1 |
| USE OF 4-(4-BROMOPHENYL)-6-METHYL-2-THIOXO-N-(O-TOLYL)-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOXAMIDE AS AGENT HAVING ANALGESIC ACTIVITY | 2024 |
|
RU2835601C1 |
| USE OF 4-[1-(4-METHYLPHENYL)AMINOETHYLIDENE]-5-PHENYL-1-CYANOMETHYLTETRAHYDROPYRROLE-2,3-DIONE AS AN ANALGESIC | 2023 |
|
RU2806330C1 |
| N-(4'-METHYLBENZOYL)-3,5-DICHLOROANTHRANILIC ACID BUTYLAMIDE EXHIBITING ANTI-INFLAMMATORY AND ANALGETIC ACTIVITY | 2020 |
|
RU2753655C1 |
| METHYL 4-HYDROXY-4-METHYL-6-PHENYL-2-CYANOACETYLHYDRAZONOCYCLOHEXANE-1-CARBOXYLATE EXHIBITING ANALGESIC ACTIVITY | 2010 |
|
RU2446150C2 |
